Genmab A/S (GNMSF)
290.00
0.00 (0.00%)
USD |
OTCM |
Mar 03, 16:00
Genmab Price : 290.00 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascendis Pharma A/S | 241.32 |
| Zealand Pharma A/S | 57.67 |
| Bavarian Nordic A/S | 9.74 |
| ALK-Abello A/S | 33.32 |
Price Related Metrics
| PE Ratio | 18.79 |
| PS Ratio | 4.965 |
| Price to Book Value | 3.054 |
| Price to Free Cash Flow | 15.85 |
| Earnings Yield | 5.32% |
| Market Cap | 17.86B |
| Operating PE Ratio | 14.78 |
| Normalized PE Ratio | 16.71 |